Sirna Therapeutics Report issue

For profit Phase 2
Founded: San Francisco CA United States (1992)
Status: Acquired by Merck (2006)

Organization Overview

First Clinical Trial
1999
NCT00002221
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2004

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Ribozyome | Sirna Therapeutics Inc.